Release Date: 22/07/09 08:37 Summary: Substantial Shareholder Notice Price Sensitive: No Download Document 46.83KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%